Amarin Corporation

Amarin a biopharmaceutical company, focuses on the development and commercialization therapeutic products. Read more

193 Followers on Owler
193 Followers on Owler
193 Followers on Owler
193 Followers on Owler

Amarin Corporation

Amarin a biopharmaceutical company, focuses on the development and commercialization therapeutic products. Read more

John Thero's photo - President & CEO of Amarin Corporation

President & CEO

John Thero

CEO Approval Rating

68/100

Founded:

1991

Status:

PrivateIndependent Company

AMARIN CORPORATION TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Apotex has been one of Amarin Corporation's top competitors. Apotex was founded in 1974, and is headquartered in Toronto, Ontario. Apotex competes in the Pharmaceuticals industry. Apotex generates $1.4B more revenue vs. Amarin Corporation.

Trygg Pharma As is a top competitor of Amarin Corporation. Trygg Pharma As is a Private company that was founded in Arlington, Virginia in null. Trygg Pharma As competes in the field. Trygg Pharma As has NaN fewer employees vs. Amarin Corporation.

Acasti Pharma is perceived as one of Amarin Corporation's biggest rivals. Acasti Pharma was founded in 2008, and its headquarters is in Laval, Quebec. Acasti Pharma is in the Health Care Services industry. Acasti Pharma has 968 fewer employees than Amarin Corporation.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 1,000 a good estimate for Amarin Corporation's Employee count?

Amarin Corporation Acquisitions

No recent acquisitions found related to Amarin Corporation

Amarin Corporation Funding History

No recent funding data found related to Amarin Corporation

Amarin Corporation Investments

No recent investments found related to Amarin Corporation

Amarin Corporation News

April 22, 2021MarketScreener

Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2

(marketscreener.com) VAZKEPA is the first and only authorized treatment for its cardiovascular risk r... See more »
April 20, 2021BioSpace

Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021

Amarin Corporation plc announced that it will host a conference call with members of Amarin senior ma... See more »
April 17, 2021MarketScreener

VASCEPA (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021

(marketscreener.com) Study quantified coronary plaque changes in patients administered 4 g/day of VAS... See more »
April 13, 2021Endpoints News

Amarin CEO John Thero passes baton to Europe commercial chief as M&A hopes continue to deflate

Karim Mikhail As Amarin breaks into the European market, John Thero is heading out. After steering th... See more »
April 12, 2021Seeking Alpha

Amarin CEO John Thero to retire

Amarin Corporation Press Releases

February 9, 2021GlobalNewswire

Amarin Provides Update on VASCEPA (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASD... See more »
November 18, 2020GlobeNewswire

Multiple New VASCEPA (Icosapent Ethyl)-Related Scientific Findings Presented at American Heart Association's Virtual Scientific Sessions 2020

Findings further support the differentiated multifactorial mechanism of action of VASCEPA and its rob... See more »
November 11, 2020GlobalNewswire

Amarin to Present at the Stifel 2020 Virtual Healthcare and Jefferies Virtual London Healthcare Conferences

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASD... See more »
September 2, 2020NewsFile

The Schall Law Firm Announces it is Investigating Claims Against Amarin Corporation plc and Encourages Investors with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 2, 2020) - The Schall Law Firm, a national shar... See more »

Social Media

Amarin Corporation Headquarters

1430 Route 206 Suite 200

Bedminster, New Jersey07921

908-719-1315

Driving Directions »

Trending Companies

Amarin Corporation Summary

ABOUT

Overview

Amarin a biopharmaceutical company, focuses on the development and commercialization therapeutic products. Amarin Corporation was founded in 1991. Amarin Corporation's headquarters is located in Bedminster, New Jersey, USA 07921. Amarin Corporation's...

CEO

Amarin Corporation's President & CEO, John Thero, currently has an approval rating of 68%. Amarin Corporation's primary competitors are Apotex, Trygg Pharma As & Acasti Pharma.

Website

amarincorp.com

Frequently Asked Questions about Amarin Corporation

  1. When was Amarin Corporation founded?

    Amarin Corporation was founded in 1991
  2. Who is Amarin Corporation's CEO?

    Amarin Corporation's CEO is John Thero
  3. How much revenue does Amarin Corporation generate?

    Amarin Corporation generates $614.1M in revenue
  4. How much funding does Amarin Corporation have?

    Amarin Corporation has historically raised $0 in funding
  1. Where is Amarin Corporation's headquarters?

    Amarin Corporation's headquarters is in Bedminster New Jersey, USA
  2. How many employees does Amarin Corporation have?

    Amarin Corporation has 1,000 employees
  3. What sector does Amarin Corporation operate in?

    Amarin Corporation is in Pharmaceuticals
  4. Who are Amarin Corporation's competitors?

    Amarin Corporation's top competitors are Apotex, Trygg Pharma As, Acasti Pharma